Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $136.48 million. The enterprise value is $15.24 million.
Important Dates
The next estimated earnings date is Thursday, May 15, 2025, before market open.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SLN has 47.22 million shares outstanding. The number of shares has increased by 24.69% in one year.
Current Share Class | n/a |
Shares Outstanding | 47.22M |
Shares Change (YoY) | +24.69% |
Shares Change (QoQ) | +0.34% |
Owned by Insiders (%) | 26.46% |
Owned by Institutions (%) | 36.57% |
Float | 23.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.68 |
Forward PS | n/a |
PB Ratio | 1.21 |
P/TBV Ratio | 1.31 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.35 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.14, with a Debt / Equity ratio of 0.00.
Current Ratio | 11.14 |
Quick Ratio | 10.36 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.08% and return on invested capital (ROIC) is -39.61%.
Return on Equity (ROE) | -58.08% |
Return on Assets (ROA) | -19.24% |
Return on Invested Capital (ROIC) | -39.61% |
Return on Capital Employed (ROCE) | -26.68% |
Revenue Per Employee | $372,914 |
Profits Per Employee | -$390,595 |
Employee Count | 116 |
Asset Turnover | 0.27 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, SLN has paid $845,000 in taxes.
Income Tax | 845,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.57% in the last 52 weeks. The beta is 1.07, so SLN's price volatility has been similar to the market average.
Beta (5Y) | 1.07 |
52-Week Price Change | -86.57% |
50-Day Moving Average | 4.60 |
200-Day Moving Average | 12.71 |
Relative Strength Index (RSI) | 28.27 |
Average Volume (20 Days) | 181,100 |
Short Selling Information
Short Interest | 1.41M |
Short Previous Month | 1.40M |
Short % of Shares Out | 2.98% |
Short % of Float | 6.03% |
Short Ratio (days to cover) | 3.56 |
Income Statement
In the last 12 months, SLN had revenue of $43.26 million and -$45.31 million in losses. Loss per share was -$0.98.
Revenue | 43.26M |
Gross Profit | 31.45M |
Operating Income | -49.58M |
Pretax Income | -52.45M |
Net Income | -45.31M |
EBITDA | -48.99M |
EBIT | -49.58M |
Loss Per Share | -$0.98 |
Full Income Statement Balance Sheet
The company has $147.33 million in cash and $117,000 in debt, giving a net cash position of $147.22 million or $3.12 per share.
Cash & Cash Equivalents | 147.33M |
Total Debt | 117,000 |
Net Cash | 147.22M |
Net Cash Per Share | $3.12 |
Equity (Book Value) | 134.02M |
Book Value Per Share | 2.84 |
Working Capital | 170.54M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$67.64 million and capital expenditures -$211,000, giving a free cash flow of -$67.85 million.
Operating Cash Flow | -67.64M |
Capital Expenditures | -211,000 |
Free Cash Flow | -67.85M |
FCF Per Share | -$1.44 |
Full Cash Flow Statement Margins
Gross margin is 72.70%, with operating and profit margins of -114.62% and -104.74%.
Gross Margin | 72.70% |
Operating Margin | -114.62% |
Pretax Margin | -102.79% |
Profit Margin | -104.74% |
EBITDA Margin | -113.25% |
EBIT Margin | -114.62% |
FCF Margin | n/a |
Dividends & Yields
SLN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.69% |
Shareholder Yield | n/a |
Earnings Yield | -27.89% |
FCF Yield | -41.77% |
Analyst Forecast
The average price target for SLN is $40.80, which is 1,311.77% higher than the current price. The consensus rating is "Buy".
Price Target | $40.80 |
Price Target Difference | 1,311.77% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SLN has an Altman Z-Score of 4.35 and a Piotroski F-Score of 3.
Altman Z-Score | 4.35 |
Piotroski F-Score | 3 |